Restrictions apply to the availability of these data, which were used under license for this study
Real health solutions require real science, professional oversight, and honesty
Eli Lilly has also released competing GLP-1 drugs in the form of Mounjaro (tirzepatide), approved for diabetes treatment in 2022, and a weight loss version of the drug was approved by the FDA last year, which is marketed under the brand name Zepbound
The National Weight Control Registry, which tracks individuals who have successfully maintained significant weight loss, identifies common characteristics including high levels of physical activity, regular breakfast consumption, consistent eating patterns across weekdays and weekends, and frequent self-weighing
Despite the fact that few insured adults say they paid the full cost of these drugs themselves, many report difficulty affording them
GLP-1 RA werden heute auch bei cv Erkrankungen und bei der Adipositas erfolgreich eingesetzt (Abb